The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator
Sneha Parekh(Icahn School of Medicine at Mount Sinai), Ash Tewari(Royal Free London NHS Foundation Trust), Daniel Ranti(Icahn School of Medicine at Mount Sinai), Ugo Giovanni Falagario(Ospedali Riuniti di Foggia), Jordan Nasri(Icahn School of Medicine at Mount Sinai), Otto Ettala(University of Turku), Giorgio Gandaglia(Vita-Salute San Raffaele University), Erik Skaaheim Haug(Oslo University Hospital), Tobias Nordström(Karolinska Institutet), Adriana M. Pedraza(Icahn School of Medicine at Mount Sinai), Ralph Grauer(Icahn School of Medicine at Mount Sinai), Luigi Cormio(University of Foggia), Alberto Briganti(University College London Hospitals NHS Foundation Trust), Alberto Martini(The University of Texas MD Anderson Cancer Center), Anna Lantz(Mount Sinai Hospital), Vinayak Wagaskar(Mount Sinai Hospital), Ivan Jambor(University of Turku), Ileana Montoya Perez(University of Turku), Hannu J. Aronen(University Medical Center Utrecht), Pekka Taimen(University of Turku), Wolfgang Picker, Parita Ratnani(Mount Sinai Hospital), Juha Knaapila(University of Turku), Giuseppe Carrieri(University of Foggia), Lajja Mistry(Icahn School of Medicine at Mount Sinai), Armando Stabile(Royal Free London NHS Foundation Trust), Michael A. Gorin(Johns Hopkins University), Zach Dovey(Mount Sinai Hospital), Dara Lundon(Icahn School of Medicine at Mount Sinai), Stanisław Sobótka(Hackensack University Medical Center), Peter J. Boström(University of Turku), Deepshikha Kewlani(Icahn School of Medicine at Mount Sinai), Mani Menon(Henry Ford Hospital), Dimitrios Stroumbakis(Icahn School of Medicine at Mount Sinai), Kenneth Haines(Mount Sinai Hospital), Peter Wiklund(Unknown)
Cited by 26
Related Papers
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
|Journal of Clinical Oncology|2020|280